| Dr Arvind K Grover, MD | |
|
2168 Millburn Ave, Maplewood, NJ 07040-2640 | |
| (973) 763-5765 | |
| (973) 763-0505 |
| Full Name | Dr Arvind K Grover |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 43 Years |
| Location | 2168 Millburn Ave, Maplewood, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306986914 | NPI | - | NPPES |
| 0285404 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MA04641800 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Grover Medical Associates Llc | 5092036137 | 2 |
News Archive
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery and real world evidence pipeline utilizing the next generation artificial intelligence, will present its research and introduce the "Cure a disease in a year" program at the World's leading congress for big data in precision medicine - Biodata World Congress 2018.
A comprehensive new gene expression study in embryonic stem cells has uncovered a transcription control mechanism that is not only more pervasive than once thought but is also heavily regulated by the cancer-causing gene c-Myc.
DuPont and Royal DSM N.V. announce an agreement to form a joint venture to develop, manufacture and commercialize advanced surgical biomedical materials, pending European Union regulatory approval. The joint venture will be named Actamax Surgical Materials LLC. Under the joint venture agreement, DuPont and DSM will each share a 50 percent interest.
› Verified 2 days ago
| Entity Name | Grover Medical Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457745572 PECOS PAC ID: 5092036137 Enrollment ID: O20150602000908 |
News Archive
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery and real world evidence pipeline utilizing the next generation artificial intelligence, will present its research and introduce the "Cure a disease in a year" program at the World's leading congress for big data in precision medicine - Biodata World Congress 2018.
A comprehensive new gene expression study in embryonic stem cells has uncovered a transcription control mechanism that is not only more pervasive than once thought but is also heavily regulated by the cancer-causing gene c-Myc.
DuPont and Royal DSM N.V. announce an agreement to form a joint venture to develop, manufacture and commercialize advanced surgical biomedical materials, pending European Union regulatory approval. The joint venture will be named Actamax Surgical Materials LLC. Under the joint venture agreement, DuPont and DSM will each share a 50 percent interest.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arvind K Grover, MD 8 Fords Rd, Randolph, NJ 07869-2123 Ph: (973) 366-6232 | Dr Arvind K Grover, MD 2168 Millburn Ave, Maplewood, NJ 07040-2640 Ph: (973) 763-5765 |
News Archive
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery and real world evidence pipeline utilizing the next generation artificial intelligence, will present its research and introduce the "Cure a disease in a year" program at the World's leading congress for big data in precision medicine - Biodata World Congress 2018.
A comprehensive new gene expression study in embryonic stem cells has uncovered a transcription control mechanism that is not only more pervasive than once thought but is also heavily regulated by the cancer-causing gene c-Myc.
DuPont and Royal DSM N.V. announce an agreement to form a joint venture to develop, manufacture and commercialize advanced surgical biomedical materials, pending European Union regulatory approval. The joint venture will be named Actamax Surgical Materials LLC. Under the joint venture agreement, DuPont and DSM will each share a 50 percent interest.
› Verified 2 days ago
Dr. Samuel T Duncan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2040 Millburn Ave, Suite 303, Maplewood, NJ 07040 Phone: 973-762-4996 Fax: 973-762-4955 | |
Shailender Karry Mohanrao, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2115 Millburn Ave, Suite L2, Maplewood, NJ 07040 Phone: 973-275-1322 Fax: 973-900-8917 | |
Dr. Segun V Simon, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2130 Millburn Ave, Suite C-3, Maplewood, NJ 07040 Phone: 973-996-2727 Fax: 973-763-2558 | |
Shirish C Patrawalla, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 264 Boyden Ave, Maplewood, NJ 07040 Phone: 973-763-4120 Fax: 973-763-1713 | |
Sunil Patel, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2010 Springfield Ave, Maplewood, NJ 07040 Phone: 973-275-9500 Fax: 973-275-9501 | |
Dr. Khalil Ahmed Kaid, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2168 Millburn Ave, Suite 204, Maplewood, NJ 07040 Phone: 973-762-3353 Fax: 973-762-3370 |